TCL Archive Learning From Europeans, U.S. Oncologists Consider Role For Oxaliplatin, 5-FU Infusion May 31, 2002
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
